Company · CIK 0001600132 · SIC 2834 — Pharmaceutical Preparations
Bellerophon Therapeutics, Inc. · BLPH
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2015 ADForm 4 → | Feb 23, 9:47 pm EST | Robert NelsenDirector, 10% Owner | 1,505,988 | — | — | 752,994 | — | plan? late |
| Feb 12, 2015 ADForm 4 → | Feb 23, 9:47 pm EST | Adam WeinsteinDirector, 10% Owner | 920,288 | — | — | 3,789,719 | — | plan? late |
| Feb 12, 2015 ADForm 4 → | Feb 23, 9:46 pm EST | Matthew S. HoltDirector, 10% Owner | 920,288 | — | — | 3,789,719 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2019 AForm 4 → | Jan 4, 4:30 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 12,500 | — | — | 260,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:30 pm EST | Peter FernandesChief Regulatory & Safety Offr | 12,500 | — | — | 294,790 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:29 pm EST | Fabian TenenbaumChief Executive Officer | 12,500 | — | — | 3,688,697 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:28 pm EST | Amy EdmondsVP Clinical Operations & Admin | 12,500 | — | — | 270,386 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:27 pm EST | Martin DekkerVP of Engineering & Manuf | 12,500 | — | — | 262,983 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:26 pm EST | Assaf KornerCFO | 12,500 | — | — | 250,000 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:25 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 137,500 | — | — | 247,500 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:25 pm EST | Peter FernandesChief Regulatory & Safety Offr | 137,500 | — | — | 282,290 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:24 pm EST | Fabian TenenbaumChief Executive Officer | 1,487,500 | — | — | 3,676,197 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:24 pm EST | Amy EdmondsVP Clinical Operations & Admin | 137,500 | — | — | 257,886 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:23 pm EST | Martin DekkerVP of Engineering & Manuf | 137,500 | — | — | 250,483 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:23 pm EST | Assaf KornerCFO | 137,500 | — | — | 237,500 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:54 pm EDT | Matthew BennettDirector | 38,216 | $2.27 | $86,750 | 38,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:53 pm EDT | Daniel TasseDirector | 38,216 | $2.27 | $86,750 | 58,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:52 pm EDT | Scott P BruderDirector | 38,216 | $2.27 | $86,750 | 83,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:50 pm EDT | Andre V. MouraDirector | 38,216 | $2.27 | $86,750 | 58,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:49 pm EDT | Mary Ann CloydDirector | 38,216 | $2.27 | $86,750 | 73,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:48 pm EDT | Jens LuehringDirector | 38,216 | $2.27 | $86,750 | 58,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:46 pm EDT | Naseem AminDirector | 38,216 | $2.27 | $86,750 | 83,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:44 pm EDT | Theodore T WangDirector, 10% Owner | 38,216 | $2.27 | $86,750 | 63,216 | — | |
| Jan 17, 2018 AForm 4 → | Jan 17, 4:52 pm EST | Assaf KornerCFO | 100,000 | — | — | 100,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 5:01 pm EST | Martin DekkerVP of Engineering & Manuf | 80,000 | — | — | 80,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 5:00 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 80,000 | — | — | 80,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:56 pm EST | Peter FernandesChief Regulatory & Safety Offr | 100,000 | — | — | 100,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:55 pm EST | Fabian TenenbaumChief Executive Officer | 550,000 | — | — | 550,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:42 pm EST | Deborah QuinnChief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:41 pm EST | Amy EdmondsVP Clinical Operations & Admin | 80,000 | — | — | 80,000 | — | |
| Dec 13, 2017 MForm 4 → | Dec 13, 4:36 pm EST | Megan SchoepsPrincipal Financial Officer | 1,000 | — | — | 3,000 | — | |
| Dec 12, 2017 AForm 4 → | Dec 14, 4:34 pm EST | Theodore T WangDirector, 10% Owner | 25,000 | — | — | 25,000 | — | |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:07 pm EDT | Naseem AminDirector | 456,432 | — | — | 456,432 | — | |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:06 pm EDT | Jens LuehringDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:06 pm EDT | Jonathan M PeacockDirector | 248,962 | — | — | 248,962 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 5:01 pm EDT | Mary Ann CloydDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 5:00 pm EDT | Naseem AminDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:59 pm EDT | Scott P BruderDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:59 pm EDT | Daniel TasseDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:56 pm EDT | Jens LuehringDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:54 pm EDT | Jonathan M PeacockDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:53 pm EDT | Adam WeinsteinDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:52 pm EDT | Andre V. MouraDirector | 10,000 | — | — | 10,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:28 pm EST | Jonathan M PeacockDirector | 588,373 | — | — | 588,373 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:27 pm EST | Martin DekkerVP of Device Engineering | 25,000 | — | — | 25,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:26 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:24 pm EST | Deborah QuinnChief Medical Officer | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:23 pm EST | Peter FernandesChief Regulatory Officer | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:22 pm EST | Amy EdmondsVP Clinical Operations & Admin | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:21 pm EST | Fabian TenenbaumChief Executive Officer | 1,042,556 | — | — | 1,042,556 | — | |
| Nov 29, 2016 PForm 5 → | Jan 2, 2018, 1:39 pm EST | Linde North America, Inc.10% Owner | 3,641,992 | — | — | 1,721,992 | — | |
| Nov 29, 2016 PForm 4 → | Dec 1, 10:57 am EST | Naseem AminDirector | 714,285 | — | — | 714,285 | — | |
| Nov 29, 2016 PForm 4 → | Dec 1, 10:40 am EST | Fabian TenenbaumChief Executive Officer | 142,857 | — | — | 142,857 | — | |
| Nov 29, 2016 PForm 4 → | Nov 30, 3:31 pm EST | Jonathan M PeacockDirector | 285,715 | — | — | 285,715 | — | |
| Nov 11, 2016 AForm 4 → | Nov 15, 5:19 pm EST | Fabian TenenbaumChief Executive Officer | 466,141 | — | — | 466,141 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:30 pm EDT | Naseem AminDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:27 pm EDT | Scott P BruderDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:24 pm EDT | Adam WeinsteinDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:21 pm EDT | Matthew S. HoltDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:17 pm EDT | Daniel TasseDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:15 pm EDT | Andre V. MouraDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:10 pm EDT | Jens LuehringDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Feb 29, 2016 AForm 4 → | Mar 1, 4:03 pm EST | Fabian TenenbaumCFO & Chief Business Officer | 130,000 | — | — | 130,000 | — | |
| Feb 11, 2016 AForm 4 → | Feb 16, 5:37 pm EST | Mary Ann CloydDirector | 25,000 | — | — | 25,000 | — | |
| Jul 8, 2015 AForm 4 → | Jul 13, 6:50 am EDT | Amit AgrawalChief Operating Officer | 100,000 | — | — | 100,000 | — | late |
| Jun 29, 2015 AForm 4 → | Jul 1, 4:59 pm EDT | Naseem AminDirector | 25,000 | — | — | 25,000 | — | |
| May 18, 2015 AForm 4 → | May 20, 8:31 pm EDT | Peter FernandesChief Regulatory Officer | 10,000 | — | — | 10,000 | — | |
| May 12, 2015 AForm 4 → | May 14, 7:37 pm EDT | R Scott HuennekensDirector | 25,000 | — | — | 25,000 | — | |
| May 12, 2015 AForm 4 → | May 14, 7:36 pm EDT | Scott P BruderDirector | 25,000 | — | — | 25,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:06 pm EDT | David AbramsTreasurer | 2,564 | — | — | 2,564 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:06 pm EDT | Reinilde HeyrmanChief Clinical Dev. Officer | 9,909 | — | — | 9,909 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:05 pm EDT | Martin MeglassonChief Scientific Officer | 8,297 | — | — | 8,297 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:03 pm EDT | Manesh NaiduChief Business Officer | 4,892 | — | — | 4,892 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:00 pm EDT | Jonathan M PeacockPresident and CEO, Director | 76,000 | — | — | 60,000 | — | |
| Feb 13, 2015 AForm 4 → | Feb 19, 5:29 pm EST | Manesh NaiduChief Business Officer | 1,995 | — | — | 1,995 | — | late |
| Feb 13, 2015 AForm 4 → | Feb 19, 5:29 pm EST | Martin MeglassonChief Scientific Officer | 1,995 | — | — | 1,995 | — | late |
| Feb 13, 2015 AForm 4 → | Feb 19, 5:28 pm EST | Reinilde HeyrmanChief Clinical Dev. Officer | 1,995 | — | — | 1,995 | — | late |
| Feb 13, 2015 AForm 4 → | Feb 19, 5:28 pm EST | David AbramsTreasurer | 1,995 | — | — | 1,995 | — | late |